Clinical trial
Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by…
NCT00294567 · Juntendo University, Other · Completed
Key facts
| NCT number | NCT00294567 |
|---|---|
| Title | Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J) |
| Official title | Azelnidipine and Amlodipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients Undergoing Coronary Intervention by Serial Volumetric Intravascular Ultrasound Analysis in Junten Medical University (ALPS-J) |
| Lead sponsor | Juntendo University, Other |
| Collaborators | Japan Heart Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Coronary Atherosclerosis |
| Intervention type | Drug |
| Interventions | Calcium channel blockers (amlodipine, azelnidipine) |
| Enrollment | 199 |
| Start date | Dec 1, 2005 |
| Primary completion | May 1, 2009 |
| Completion | Jan 1, 2011 |
| First posted | Feb 22, 2006 |
| Last update posted | May 14, 2021 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: